Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Mol Psychiatry. 2013 Jul;18(7):739. doi: 10.1038/mp.2013.81

Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics

K Nho 1, JJ Corneveaux 2, S Kim 1,3, H Lin 3, SL Risacher 1, L Shen 1,3, S Swaminathan 1,4, VK Ramanan 1,4, Y Liu 3,4, T Foroud 1,3,4, MH Inlow 5, AL Siniard 2, RA Reiman 2, PS Aisen 6, RC Petersen 7, RC Green 8, CR Jack 7, MW Weiner 9,10, CT Baldwin 11, K Lunetta 12, LA Farrer 11,13, SJ Furney 14,15,16, S Lovestone 14,15,16, A Simmons 14,15,16, P Mecocci 17, B Vellas 18, M Tsolaki 19, I Kloszewska 20, H Soininen 21, BC McDonald 1,22, MR Farlow 22, B Ghetti 23, MJ Huentelman 2, AJ Saykin 1,3,4,22, for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study; for the AddNeuroMed Consortium; for the Indiana Memory and Aging Study; for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
PMCID: PMC3777293  NIHMSID: NIHMS502901  PMID: 23787478

graphic file with name nihms502901u1.jpg

The image illustrates the schematic view for discovery of functional variants from whole-exome sequencing. We report on a novel strategy combining whole-exome sequencing and neuroimaging genetics to identify functional variants associated with the rate of hippocampal volume loss in mild cognitive impairment. Whole-exome sequencing was performed on a modest sample using an extreme trait design by selecting individuals at the extremes of the distribution of 2-year longitudinal change in hippocampal volume. To further investigate and extend the exome findings in a larger sample, we conducted quantitative trait analysis, including whole-brain search, combined with genotype imputation. Finally, meta-analysis was performed to validate the exome findings across five independent cross-sectional cohorts. Combining next-generation sequencing and quantitative imaging phenotypes holds promise for the discovery of variants involved in neurodegeneration and other brain disorders. For more information on this topic, please refer to the article by Nho et al. on pages 781–787.

RESOURCES